Insight

Research into why some respond to TKIs better than others – Oncogene Cancer Research

Oncogene Cancer Research/LinkedIn

Jun 20, 2024, 12:07

Research into why some respond to TKIs better than others – Oncogene Cancer Research

Oncogene Cancer Research recently shared a post on X:

“Worth reading this deep dive into ‘mechanistic patterns and clinical implications of oncogenic tyrosine kinase fusions in human cancers’ via Nature Cancer.

Research into why some respond to TKIs better than others and more.”

Oncogene Cancer Research

Read further
Source: Oncogene Cancer Research/X

Ahram Jang Alessandro Di Federico Biagio Ricciuti cancer clinical implications Giulia Leonardi João Alessi Maria Lehtinen Marian Harris Mark Awad mechanistic patterns Nature Medicine OncoDaily Oncogene Cancer Research Oncology Qi Wang Roberto Chiarle Taek-Chin Cheong TKI tyrosine kinase

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage